BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8677116)

  • 41. Adverse effects associated with contraceptive implants: incidence, prevention and management.
    Singh K; Chye GC
    Adv Contracept; 1998 Mar; 14(1):1-13. PubMed ID: 9587004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fulminant thrombotic thrombocytopenic purpura in the course of ciprofloxacin therapy].
    Mouraux A; Gille M; PiƩret F; Declercq I
    Rev Neurol (Paris); 2002 Nov; 158(11):1115-7. PubMed ID: 12451346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is ticlopidine really responsible for thrombotic thrombocytopenic purpura (TTP)?
    Centurioni R; Candela M; Leoni P; Minnucci ML; Danieli G
    Haematologica; 1993; 78(3):196-7. PubMed ID: 8375754
    [No Abstract]   [Full Text] [Related]  

  • 44. Niacin toxicity resulting from urine drug test evasion.
    Daul AM; Beuhler MC
    J Emerg Med; 2011 Sep; 41(3):e65-8. PubMed ID: 20138459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The downfall of Norplant.
    Leifer D
    Nurs Stand; 1999 Jun 2-8; 13(37):14-5. PubMed ID: 10455680
    [No Abstract]   [Full Text] [Related]  

  • 46. The Norplant System: where are we in 1995?
    Thomas AG; LeMelle SM
    J Fam Pract; 1995 Feb; 40(2):125-8. PubMed ID: 7852933
    [No Abstract]   [Full Text] [Related]  

  • 47. The Norplant contraceptive.
    Lawless BG; Howell RI; Peters PL
    J Fam Pract; 1992 Sep; 35(3):248-9; author reply 249, 252-3. PubMed ID: 1517715
    [No Abstract]   [Full Text] [Related]  

  • 48. Norplant recalled.
    Cockey CD
    AWHONN Lifelines; 2000 Dec-2001 Jan; 4(6):17. PubMed ID: 11898166
    [No Abstract]   [Full Text] [Related]  

  • 49. The Norplant contraceptive.
    Reynolds RD
    J Fam Pract; 1992 Sep; 35(3):249; author reply 249, 252-3. PubMed ID: 1517716
    [No Abstract]   [Full Text] [Related]  

  • 50. Politics trumps science at the FDA.
    Lancet; 2005 Nov; 366(9500):1827. PubMed ID: 16310533
    [No Abstract]   [Full Text] [Related]  

  • 51. Cost of Norplant.
    Reynolds RD
    Am Fam Physician; 1994 Sep; 50(3):539, 542. PubMed ID: 8067322
    [No Abstract]   [Full Text] [Related]  

  • 52. Thrombotic thrombocytopenic purpura does not show seasonal variation in Alabama.
    Scott JL; McCleskey B; Adamski J; Marques MB
    Transfusion; 2013 Aug; 53(8):1864-5. PubMed ID: 23927642
    [No Abstract]   [Full Text] [Related]  

  • 53. Lemierre's Syndrome: A Case Report.
    Doan H; Niyazi S; Burton A; Nibir I; Kavaliauskas A
    Cureus; 2021 Apr; 13(4):e14713. PubMed ID: 34055552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.
    Zheng XL; Vesely SK; Cataland SR; Coppo P; Geldziler B; Iorio A; Matsumoto M; Mustafa RA; Pai M; Rock G; Russell L; Tarawneh R; Valdes J; Peyvandi F
    J Thromb Haemost; 2020 Oct; 18(10):2503-2512. PubMed ID: 32914535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "Almost bleeding to death": the conundrum of acquired amegakaryocytic thrombocytopenia.
    Brown GE; Babiker HM; Cantu CL; Yeager AM; Krishnadasan R
    Case Rep Hematol; 2014; 2014():806541. PubMed ID: 24649385
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Refractory thrombotic thrombocytopenic purpura associated with oral contraceptives and factor V Leiden: a case report.
    Stylianou K; Tsirakis G; Mantadakis E; Xylouri I; Foudoulakis A; Vardaki E; Katsipi I; Daphnis E; Samonis G
    Cases J; 2009 May; 2():6611. PubMed ID: 19829833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible association between the Norplant contraceptive system and thrombotic thrombocytopenic purpura.
    Fraser JL; Millenson M; Malynn ER; Uhl L; Kruskall MS
    Obstet Gynecol; 1996 May; 87(5 Pt 2):860-3. PubMed ID: 8677116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Wysowski DK; Green L
    Obstet Gynecol; 1995 Apr; 85(4):538-42. PubMed ID: 7898829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.